Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen
Advertisement
The Board of Directors of Nuevolution unanimously recommends the shareholders of Nuevolution to accept the public offer from Amgen of SEK 32.50 in cash per share